Journal article
Usefulness of statins in end-stage renal disease
Proceedings - Baylor University. Medical Center, Vol.34(3), pp.361-363
02/05/2021
DOI: 10.1080/08998280.2021.1874774
PMCID: PMC8059899
PMID: 33953460
Abstract
End-stage renal disease (ESRD) is considered an independent risk factor of cardiovascular and cerebrovascular events. This review highlights atherosclerotic risk, lipid metabolism alterations, and four studies on the use of statins in ESRD-two of which showed a statistically significant effect of statins on the primary endpoints and two of which did not. Since effects were seen with higher doses of statins, further research is needed on the protective effects of intermediate to higher doses of statins in ESRD patients.
Details
- Title: Subtitle
- Usefulness of statins in end-stage renal disease
- Creators
- Mahmoud Abdelnabi - Alexandria UniversityNouran Eshak - Texas Tech University Health Sciences CenterAbdallah Almaghraby - Alexandria UniversityYehia Saleh - Houston MethodistFady Gerges - Department of Cardiovascular Science, Mediclinic Al Jowhara HospitalAshraf Ahmed - Alexandria University
- Resource Type
- Journal article
- Publication Details
- Proceedings - Baylor University. Medical Center, Vol.34(3), pp.361-363
- DOI
- 10.1080/08998280.2021.1874774
- PMID
- 33953460
- PMCID
- PMC8059899
- NLM abbreviation
- Proc (Bayl Univ Med Cent)
- ISSN
- 0899-8280
- eISSN
- 1525-3252
- Publisher
- Taylor & Francis
- Number of pages
- 3
- Language
- English
- Date published
- 02/05/2021
- Academic Unit
- Internal Medicine
- Record Identifier
- 9984756267602771
Metrics
6 Record Views